Balyasny Asset Management
GH icon

Balyasny Asset Management’s Guardant Health GH Stock Holding History

Balyasny Asset Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.7M Buy
+124,368
New +$13.5M 0.02% 754
2026
Q1 		– Sell
-505,608
Closed -$51.6M – 3122
2025
Q4 		$51.6M Sell
505,608
-27,769
-5% -$2.48M 0.07% 346
2025
Q3 		$33.3M Sell
533,377
-30,971
-5% -$1.68M 0.04% 507
2025
Q2 		$29.4M Sell
564,348
-274,644
-33% -$12.3M 0.04% 524
2025
Q1 		$35.7M Sell
838,992
-153,546
-15% -$6.62M 0.06% 394
2024
Q4 		$30.3M Sell
992,538
-30,679
-3% -$863K 0.05% 496
2024
Q3 		$23.5M Buy
+1,023,217
New +$29M 0.04% 569
2024
Q2 		– Sell
-100,519
Closed -$2.07M – 2761
2024
Q1 		$2.07M Sell
100,519
-300,379
-75% -$6.44M ﹤0.01% 1534
2023
Q4 		$10.8M Sell
400,898
-394,335
-50% -$10.3M 0.02% 833
2023
Q3 		$23.6M Buy
795,233
+761,873
+2,284% +$26.8M 0.05% 517
2023
Q2 		$1.19M Sell
33,360
-1,531,621
-98% -$44M ﹤0.01% 1554
2023
Q1 		$36.7M Buy
1,564,981
+463,183
+42% +$13.2M 0.09% 311
2022
Q4 		$30M Buy
1,101,798
+799,736
+265% +$36.6M 0.08% 326
2022
Q3 		$16.3M Sell
302,062
-164,698
-35% -$8.46M 0.05% 499
2022
Q2 		$18.8M Sell
466,760
-339,749
-42% -$16.8M 0.06% 440
2022
Q1 		$53.4M Buy
806,509
+330,327
+69% +$22.6M 0.17% 127
2021
Q4 		$47.6M Buy
+476,182
New +$49.3M 0.16% 144
2021
Q3 		– Sell
-270,947
Closed -$33.6M – 2108
2021
Q2 		$33.6M Buy
+270,947
New +$36.4M 0.16% 156
2021
Q1 		– Sell
-190,022
Closed -$24.5M – 1878
2020
Q4 		$24.5M Buy
190,022
+150,734
+384% +$17.3M 0.14% 204
2020
Q3 		$4.39M Buy
39,288
+13,406
+52% +$1.23M 0.03% 650
2020
Q2 		$2.1M Buy
+25,882
New +$2.09M 0.02% 714

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Balyasny Asset Management's GH Position: Q2 2026 in Review

Balyasny Asset Management opened a new position in Guardant Health (GH) in Q2 2026: 124,368 shares worth $18.7M. The stake represents 0.02% of the portfolio and ranks #754 among its holdings. This is a return to the name: Balyasny Asset Management previously reported a position in GH as recently as Q4 2025.

Balyasny Asset Management first reported a position in GH in Q2 2020 and has held it in 21 quarters since. The position peaked at $53.4M in Q1 2022. 598 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Balyasny Asset Management held 124,368 shares of Guardant Health worth $18.7M as of Q2 2026.
  • Guardant Health was a new Balyasny Asset Management position in Q2 2026.
  • Guardant Health made up 0.02% of Balyasny Asset Management's portfolio in Q2 2026, its #754 holding.
  • Balyasny Asset Management first reported a position in Guardant Health in Q2 2020 and has held it in 21 quarters since.
  • Balyasny Asset Management's Guardant Health position peaked at $53.4M in Q1 2022.
  • 598 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.